Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| retinal cone cell | 9 studies | 79% ± 17% | |
| retinal rod cell | 9 studies | 78% ± 17% | |
| retinal bipolar neuron | 3 studies | 25% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| eye | 7 studies | 49% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 83% | 8.46 | 2204 / 2642 | 3% | 0.04 | 18 / 705 |
| prostate | 79% | 4.29 | 194 / 245 | 2% | 0.03 | 9 / 502 |
| thymus | 80% | 5.43 | 525 / 653 | 0% | 0.01 | 2 / 605 |
| uterus | 78% | 4.31 | 133 / 170 | 1% | 0.03 | 6 / 459 |
| intestine | 76% | 4.04 | 733 / 966 | 3% | 0.09 | 17 / 527 |
| muscle | 79% | 4.49 | 632 / 803 | 0% | 0 | 0 / 0 |
| esophagus | 66% | 3.35 | 957 / 1445 | 11% | 0.21 | 21 / 183 |
| pancreas | 75% | 4.11 | 246 / 328 | 2% | 0.02 | 3 / 178 |
| skin | 75% | 4.99 | 1356 / 1809 | 1% | 0.01 | 4 / 472 |
| lung | 72% | 3.60 | 416 / 578 | 4% | 0.19 | 41 / 1155 |
| breast | 73% | 4.19 | 335 / 459 | 2% | 0.11 | 23 / 1118 |
| bladder | 71% | 3.95 | 15 / 21 | 3% | 0.10 | 13 / 504 |
| heart | 73% | 3.87 | 631 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 73% | 4.08 | 972 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 70% | 3.64 | 841 / 1204 | 0% | 0 | 0 / 0 |
| stomach | 63% | 2.94 | 227 / 359 | 6% | 0.16 | 17 / 286 |
| ovary | 56% | 2.53 | 100 / 180 | 1% | 0.03 | 6 / 430 |
| liver | 56% | 2.39 | 126 / 226 | 0% | 0 | 0 / 406 |
| kidney | 48% | 1.64 | 43 / 89 | 1% | 0.03 | 5 / 901 |
| adrenal gland | 45% | 1.58 | 115 / 258 | 0% | 0.03 | 1 / 230 |
| spleen | 42% | 1.69 | 101 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 29% | 1.72 | 267 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 8% | 3.31 | 6 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007601 | Biological process | visual perception |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0008277 | Biological process | regulation of G protein-coupled receptor signaling pathway |
| GO_0007602 | Biological process | phototransduction |
| GO_0001917 | Cellular component | photoreceptor inner segment |
| GO_0005829 | Cellular component | cytosol |
| GO_0001750 | Cellular component | photoreceptor outer segment |
| GO_0005634 | Cellular component | nucleus |
| GO_0004859 | Molecular function | phospholipase inhibitor activity |
| Gene name | PDC |
| Protein name | Phosducin Phosducin (PHD) (33 kDa phototransducing protein) (Protein MEKA) |
| Synonyms | |
| Description | FUNCTION: May participate in the regulation of visual phototransduction or in the integration of photoreceptor metabolism. Inhibits the transcriptional activation activity of the cone-rod homeobox CRX. . |
| Accessions | ENST00000391997.3 [P20941-1] Q52LP8 P20941 ENST00000497198.1 [P20941-2] |